Table 4.
Characteristics of the HIV subjects with active tuberculosis
| Subject | Demographics | Baseline HIV parameters | Clinical presentation |
|---|---|---|---|
| 1 | 47y | CD4: 68 (6%) | Unmasking miliary TB-IRIS |
| Caucasian | VL: not tested | ||
| cART: yes | |||
| 2 | 42y | CD4:124 (14%) | Miliary TB |
| Sub saharan | VL: 712000 | ||
| cART: no | |||
| 3 | 28y | CD4: 26 (6%) | Miliary TB |
| Sub saharan | VL: 8070000 | ||
| cART: no | |||
| 4 | 38y | CD4: 141 (35%) | Pulmonary TB |
| Sub saharan | VL < 40 | ||
| cART: yes | |||
| 5 | 38y | CD4: 25 (5%) | Pulmonary and ganglionary TB |
| Sub saharan | VL: 201000 | ||
| cART: no | |||
| 6 | 43y | CD4: 580 (37%) | ART-associated Pleuro-pulmonary TB |
| Sub saharan | VL <40 | ||
| cART: yes |
ART: antiretroviral therapy; cART: combination ART; CD4: CD4+ T cell count cells/mm3 (percentage); TB: Tuberculosis; TB-IRIS: TB-associated immune reconstitution inflammatory syndrome; VL: viral load (copies/ml); y: years.